期刊文献+

2型糖尿病患者血清GLP-1水平及其临床意义 被引量:1

Discussion on serum GLP-1 levels and clinical significance in patients with Type 2 diabetes
下载PDF
导出
摘要 目的:研究GLP-1在2型糖尿病患者血清中的水平变化与疾病发生、发展的关系。方法:采用ELISA法检测36例2型糖尿病患者和33例健康对照者血清中GLP-1浓度。结果:2型糖尿病患者血清中GLP-1浓度水平明显低于健康对照者,差异有统计学意义(P〈0.05)。结论:血清GLP-1浓度与2型糖尿病发生有一定的相关性,为2型糖尿病的诊断与预防提供了新线索。 Objective: To investigate the changes of serum GLP-1 level in the pathologic process of type 2 diabetes. Methods: Serum levels of GLP-1 of 36 patients with type 2 diabetes and 33 healthy controls were detected by ELISA, Results: Serum levels of GLP-1 in type 2 diabetes patients were statistically lower than that in healthy controls (P〈0.05) .Conclusions: Serum GLP-1 might be involved in the pathogenesis of type 2 diabetes and would be a prevention or therapy target in the development of type 2 diabetes.
出处 《医学检验与临床》 2016年第4期10-11,共2页 Medical Laboratory Science and Clinics
关键词 2型糖尿病 GLP-1 ELISA 胰岛素分泌 Type 2 diabetes GLP-1 ELISA insulin secretion
  • 相关文献

参考文献7

  • 1Olokoba A B, Obatern O A, Olokoba L B. Type 2 diabetes mellitus: a review of current trends[J]. Oman Med J, 2012,27(4) : 269-273.
  • 2Mizokami A,Yasutake Y,Gao J,et al.Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice [J]. PloS one,2013,8(2) : e57375.
  • 3Green C J,Henriksen T I,Pedersen B K,et al. Glucagon like peptide -1 -induced glucose metabolism in differentiated human muscle satellite cells is attenuated by hyperglycemia [J]. 2012. 9 (4): 478-480.
  • 4Aoki K,Kamiyama H,Masuda K,et al. Mosapride citrate,a 5-HT 4 receptor agonist,increased the plasma active and total glucagon-like peptide-1 levels in non-diabetic men [J]. Endocrine journal 2013 60(4) : 493-499.
  • 5Meloni A P~, DeYoung M B, Lowe C,et al. GLP-1 receptoractivated insulin secretion from pancereatic [3-cell:mechanism and glucose dependenc [J]. Diabetes,Obesity and Metabolism,2013,15(1):15-27 .
  • 6Murakami M,Une N, Nishizawa M, et al.Incretin secretion stimulated by ursodeoxycholic acid in healthy subjects[J]. Springerplus,2013,2(1):96-100.
  • 7Puddu A,Mach F,Nencioni A,et aLAn emerging role of glucagon-like?peptide-1 in preventing advanced- glycation -end -product -mediated damages in diabetes [J].Mediators of inflammation,2013,56 (4): 124-128.

同被引文献10

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部